262 related articles for article (PubMed ID: 30578939)
1. Incidence of Adenovirus Infection in Hematopoietic Stem Cell Transplantation Recipients: Findings from the AdVance Study.
Sedláček P; Petterson T; Robin M; Sivaprakasam P; Vainorius E; Brundage T; Chandak A; Mozaffari E; Nichols G; Voigt S
Biol Blood Marrow Transplant; 2019 Apr; 25(4):810-818. PubMed ID: 30578939
[TBL] [Abstract][Full Text] [Related]
2. Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.
Papanicolaou GA; Dvorak CC; Dadwal S; Maron G; Prasad VK; Giller R; Abdel-Azim H; Sadanand A; Casciano R; Chandak A; Huang S; Nichols G; Brundage T; Vainorius E; Mozaffari E; Hutcheson R
Transpl Infect Dis; 2020 Aug; 22(4):e13283. PubMed ID: 32267590
[TBL] [Abstract][Full Text] [Related]
3. Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study.
González-Vicent M; Verna M; Pochon C; Chandak A; Vainorius E; Brundage T; Mozaffari E; Nichols G; Rao K
Eur J Haematol; 2019 Mar; 102(3):210-217. PubMed ID: 30418684
[TBL] [Abstract][Full Text] [Related]
4. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.
Lee YJ; Chung D; Xiao K; Papadopoulos EB; Barker JN; Small TN; Giralt SA; Zheng J; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):387-92. PubMed ID: 23092814
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.
Lee YJ; Huang YT; Kim SJ; Maloy M; Tamari R; Giralt SA; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2016 Jan; 22(1):174-8. PubMed ID: 26318614
[TBL] [Abstract][Full Text] [Related]
7. Association between adenovirus viral load and mortality in pediatric allo-HCT recipients: the multinational AdVance study.
Zecca M; Wynn R; Dalle JH; Feuchtinger T; Vainorius E; Brundage TM; Chandak A; Mozaffari E; Nichols G; Locatelli F
Bone Marrow Transplant; 2019 Oct; 54(10):1632-1642. PubMed ID: 30804489
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.
Lee YJ; Fang J; Zavras PD; Prockop SE; Boulad F; Tamari R; Perales MA; Papadopoulos EB; Jakubowski AA; Giralt SA; Papanicolaou GA
J Infect Dis; 2020 Sep; 222(7):1180-1187. PubMed ID: 32374872
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival.
Bruno B; Gooley T; Hackman RC; Davis C; Corey L; Boeckh M
Biol Blood Marrow Transplant; 2003 May; 9(5):341-52. PubMed ID: 12766884
[TBL] [Abstract][Full Text] [Related]
10. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.
Watson T; MacDonald D; Song X; Bromwich K; Campos J; Sande J; DeBiasi RL
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1227-34. PubMed ID: 22281300
[TBL] [Abstract][Full Text] [Related]
12. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK
Biol Blood Marrow Transplant; 2017 Mar; 23(3):512-521. PubMed ID: 28063938
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Human Adenovirus Infection and Disease in a Retrospective Cohort of Pediatric Hematopoietic Cell Transplant Recipients.
Fisher BT; Boge CLK; Petersen H; Seif AE; Bryan M; Hodinka RL; Cardenas AM; Purdy DR; Loudon B; Kajon AE
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):317-324. PubMed ID: 29893957
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome.
Watcharananan SP; Kiertiburanakul S; Piyatuctsanawong W; Anurathapan U; Sungkanuparph S; Pakakasama S; Chantratita W; Hongeng S
Pediatr Transplant; 2010 Aug; 14(5):675-81. PubMed ID: 20412509
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation.
Wang Y; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Wei F; Han W; Wang F; Wang J; Huang X; Mo X
Virol J; 2024 May; 21(1):110. PubMed ID: 38745209
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis.
Inamoto Y; Takeda W; Hirakawa T; Sakaguchi H; Nakano N; Uchida N; Doki N; Ikegame K; Katayama Y; Sawa M; Kuriyama T; Hiramoto N; Ota S; Ozawa Y; Kataoka K; Kanda Y; Hino M; Kimura T; Atsuta Y; Fukuda T; Nagafuji K
Am J Hematol; 2022 Dec; 97(12):1568-1579. PubMed ID: 36087061
[TBL] [Abstract][Full Text] [Related]
17. Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34
Huang YT; Kim SJ; Lee YJ; Burack D; Nichols P; Maloy M; Perales MA; Giralt SA; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1759-1766. PubMed ID: 28668490
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
[TBL] [Abstract][Full Text] [Related]
19. A survey on incidence and management of adenovirus infection after allogeneic HSCT.
Cesaro S; Berger M; Tridello G; Mikulska M; Ward KN; Ljungman P; Van Der Werf S; Averbuch D; Styczynski J;
Bone Marrow Transplant; 2019 Aug; 54(8):1275-1280. PubMed ID: 30546071
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.
Ip W; Silva JMF; Gaspar H; Mitra A; Patel S; Rao K; Chiesa R; Amrolia P; Gilmour K; Ahsan G; Slatter M; Gennery AR; Wynn RF; Veys P; Qasim W
Cytotherapy; 2018 Jun; 20(6):830-838. PubMed ID: 29753677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
